The publication of a positive study about a company's product generally leads to increased investor confidence, which can drive up the stock price. In this case, the study shows that NeurAxis's product, IB-Stim, improves the quality of life of adolescents with IBS, which is a significant market. This could lead to increased sales and revenue for the company, further boosting the stock price.